Tech Company Financing Transactions

QuatRx Pharmaceuticals Funding Round

Thomas Weisel Venture Partners, Frazier Healthcare Partners and InterWest Partners joined a $31 million Series C venture round for QuatRx Pharmaceuticals. The round was announced on 12/13/2004.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

777 East Eisenhower Pkwy. 100
Ann Arbor, MI 48108
USA

Phone

(734) 913-9900

Website

www.quatrx.com

Email Address

[email protected]

Overview

QuatRx Pharmaceuticals Company is a pharmaceutical company focused on discovering, licensing, developing and commercializing compounds in the endocrine, metabolic and cardiovascular therapeutic areas.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Robert Zerbe

        

Chief Financial Officer

Gary Onn

        

Chief Operating Officer

Christopher Nicholas

        

Chief Scientific Officer

Stuart Dombey

        

Browse more venture capital transactions:

Prev: 12/13/2004: Atraverda venture capital transaction
Next: 12/13/2004: Neotropix venture capital transaction

Share this article

Where The Data Comes From

We report on every notable VC transaction. VC investment data records on this site come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary